Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-008278
Filing Date
2025-02-03
Accepted
2025-02-03 06:00:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm254033-1_424b5.htm 424B5 674759
2 GRAPHIC lg_annovis-4c.jpg GRAPHIC 17624
  Complete submission text file 0001104659-25-008278.txt   700265
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276814 | Film No.: 25580384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)